Research And Diagnostic Systems, Inc. Sustainability Profile
Research And Diagnostic Systems, Inc. (R&D Systems), headquartered in the United States, is a leading provider in the biotechnology industry, specialising in the development of high-quality research and diagnostic tools. Founded in 1977, the company has established a strong presence in major operational regions across North America and Europe. R&D Systems is renowned for its extensive range of products, including antibodies, proteins, and assay kits, which are pivotal for scientific research and clinical diagnostics. Their commitment to innovation and quality has positioned them as a trusted partner for researchers worldwide. Notable achievements include numerous collaborations with academic institutions and contributions to significant advancements in life sciences. With a focus on precision and reliability, R&D Systems continues to support the evolving needs of the scientific community.
DitchCarbon Score
How does Research And Diagnostic Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Research And Diagnostic Systems, Inc.'s score of 42 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Research And Diagnostic Systems, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Bio-Techne Corporation, which may influence its climate commitments and performance metrics. As part of its corporate family, Research And Diagnostic Systems, Inc. inherits climate initiatives and targets from Bio-Techne Corporation. However, there are no documented reduction targets or specific climate pledges available for this subsidiary. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. In the context of the industry, it is essential for organisations like Research And Diagnostic Systems, Inc. to establish clear carbon reduction goals and report emissions transparently to align with global climate standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 2,684,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 12,694,000 | 00,000,000 | 00,000,000 | - |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Research And Diagnostic Systems, Inc.'s Industry?
How Carbon Intensive is Research And Diagnostic Systems, Inc.'s Location?
Research And Diagnostic Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Research And Diagnostic Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
